Daniel L. Labovitz, Jonathan M. Gursky, Victor Ferastraoaru, Jillian Rosengard, Phillip Cezayirli, David Flomenbaum, Daniel Antoniello, Peter Semczuk, Aureliana Toma, Ryan Holland, Elisabetta Burchi, Emad N. Eskandar, Judah Burns, Jenelys Fernandez-Torres, Alexis Boro, Rafael De la Garza Ramos, Avinash Malaviya, Nikunj K. Patel, Michelle N. Gong, Kevin Hsu, Mark J. Milstein, David J. Altschul, Amichai Erdfarb, Andrew Mcclelland, Mark F. Mehler, Jenny Lu, Joseph Dardick, Charles Esenwa, Santiago R. Unda, Joshua A. Benton, Rishi Malhotra, and Richard L. Zampolin
ObjectiveSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is protean in its manifestations, affecting nearly every organ system. However, nervous system involvement and its effect on disease outcome are poorly characterized. The objective of this study was to determine whether neurologic syndromes are associated with increased risk of inpatient mortality.MethodsA total of 581 hospitalized patients with confirmed SARS-CoV-2 infection, neurologic involvement, and brain imaging were compared to hospitalized non-neurologic patients with coronavirus disease 2019 (COVID-19). Four patterns of neurologic manifestations were identified: acute stroke, new or recrudescent seizures, altered mentation with normal imaging, and neuro-COVID-19 complex. Factors present on admission were analyzed as potential predictors of in-hospital mortality, including sociodemographic variables, preexisting comorbidities, vital signs, laboratory values, and pattern of neurologic manifestations. Significant predictors were incorporated into a disease severity score. Patients with neurologic manifestations were matched with patients of the same age and disease severity to assess the risk of death.ResultsA total of 4,711 patients with confirmed SARS-CoV-2 infection were admitted to one medical system in New York City during a 6-week period. Of these, 581 (12%) had neurologic issues of sufficient concern to warrant neuroimaging. These patients were compared to 1,743 non-neurologic patients with COVID-19 matched for age and disease severity admitted during the same period. Patients with altered mentation (n = 258, p = 0.04, odds ratio [OR] 1.39, confidence interval [CI] 1.04–1.86) or radiologically confirmed stroke (n = 55, p = 0.001, OR 3.1, CI 1.65–5.92) had a higher risk of mortality than age- and severity-matched controls.ConclusionsThe incidence of altered mentation or stroke on admission predicts a modest but significantly higher risk of in-hospital mortality independent of disease severity. While other biomarker factors also predict mortality, measures to identify and treat such patients may be important in reducing overall mortality of COVID-19.